{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T01:22:51Z","timestamp":1777339371049,"version":"3.51.4"},"reference-count":47,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"published-print":{"date-parts":[[2019,10,31]]},"abstract":"<jats:p>In this study, two extracts from Fatsia japonica-Fatsiphloginum\u2122 (extract of triterpene glycosides containing 45-50 % of fatsiosides (FS)) and purified triterpene-rich extract of saponins with code name PS-551 (PS) were administered in combination with methotrexate (MTX) and in monotherapy to rats suffering adjuvant arthritis (AA). The anti-inflammatory activities of extracts were evaluated as monotherapies in comparison with untreated AA. PS administered in higher dose showed on day 28 effective decrease of hind paw volume (HPV), decreased activity of gamma-glutamyl transferase (GGT) in joints, and also interleukin-17A was decreased significantly on day 14. The higher dose of PS was more effective than both doses of FS. Further, we evaluated the higher doses of PS and FS in combination with MTX. PS improved the effect of MTX in combination more effective than FS (HPV, body weight and activity of GGT in joint). However, FS was more effective in reducing the level of IL-17A on day 14 and activity of GGT in spleen than PS. In conclusion, our study showed that generally FS has higher anti-arthritic activity comparing to PS. Thus, the novel combination of Fatsiphloginum\u2122 and methotrexate could be interesting for future clinical studies in patients suffering auto-immune diseases.<\/jats:p>","DOI":"10.33549\/physiolres.934328","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T14:41:22Z","timestamp":1574952082000},"page":"S75-S85","source":"Crossref","is-referenced-by-count":6,"title":["Study of Anti-Inflammatory Activity of Fatsiphloginum\u2122 (Fatsia japonica) and a New Purified Triterpene-Rich Extract of Saponins (PS-551) in Experimental Model of Arthritis"],"prefix":"10.33549","author":[{"given":"L.","family":"TSIKLAURI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"DRAFI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"PONI\u0160T","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"SLOV\u00c1K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"CHRASTINA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"\u0160V\u00cdK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"KEMOKLIDZE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"KEMERTELIDZE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"BAUEROV\u00c1","sequence":"additional","affiliation":[{"name":"Institute of Experimental Pharmacology and Toxicology, Centre of Experimental Medicine,  Slovak Academy of Sciences, Bratislava, Slovak Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"19169","published-online":{"date-parts":[[2019,11,3]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"ACR (American College of Rheumatology) Subcommittee on Rheumatoid Arthritis Guidelines: Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 46: 328-346, 2002.","DOI":"10.1002\/art.10148"},{"key":"ref1","unstructured":"BAUEROVA K, PONIST S, ONDREJICKOVA O, KOMENDOVA D, MIHALOVA D: Association between tissue gamma-glutamyl-transferase and clinical markers of adjuvant arthritisin Lewis rats. Neuroendocrinol Lett 27: 172-175, 2006."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"BAUEROVA K, KUCHARSKA J, PONIST S, GVOZDJAKOVA A: Coenzyme Q10 supplementation in adjuvant arthritis (pre-clinical study). In: Mitochondrial Medicine: Mitochodrial Metabolism, Diseases, Diagnosis and Therapy. GVOZDJAKOVA A (ed.), Springer Verlak, Berlin, 2008a, pp 340-342.","DOI":"10.1007\/978-1-4020-6714-3_18"},{"key":"ref3","unstructured":"BAUEROVA K, PONIST S, NAVAROVA J, DUBNICKOVA M, PAULOVICOVA E, PAJTINKA M, KOGAN G, MIHALOVA D: Glucomannan in prevention of oxidative stress and inflammation occurring in adjuvant arthritis. Neuroendocrinol Lett 29: 691-696, 2008b."},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"BAUEROVA K, PAULOVICOVA E, MIHALOVA D, SVIK K, PONIST S: Study of new ways of supplementary and combinatory therapy of rheumatoid arthritis with immunomodulators. Glucomannan and Imunoglukan in adjuvant arthritis. Toxicol Ind Health 25: 329-335, 2009.","DOI":"10.1177\/0748233709102945"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"BAUEROVA K, PAULOVICOVA E, MIHALOVA D, DRAFI F, STROSOVA M, MASCIA C, BIASI F, ROVENSKY J, KUCHARSKA J, GVOZDJAKOVA A, PONIST S: Combined methotrexate and coenzyme Q10 therapy in adjuvant-induced arthritis evaluated using parameters of inflammation and oxidative stress. Acta Biochim Pol 57: 347-354, 2010.","DOI":"10.18388\/abp.2010_2415"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"BAUEROV\u00c1 K, PONI\u0160T S, MIHALOV\u00c1 D, DR\u00c1FI F, KUNC\u00cdROV\u00c1 V: Utilization of adjuvant arthritis model for evaluation of new approaches in rheumatoid arthritis therapy focused on regulation of immune processes and oxidative stress. Interdiscip Toxicol 4: 33-39, 2011.","DOI":"10.2478\/v10102-011-0007-9"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"BAUEROVA K, ACQUAVIVA A, PONIST S, GARDI C, VECCHIO D, DRAFI F, AREZZINI B, BEZAKOVA L, KUNCIROVA V, MIHALOVA D, NOSAL R: Markers of inflammation and oxidative stress studied in adjuvant-induced arthritis in the rat on systemic and local level affected by pinosylvin and methotrexate and their combination. Autoimmunity 48: 46-56, 2015.","DOI":"10.3109\/08916934.2014.939268"},{"key":"ref8","unstructured":"BENDELE AM: Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact 1: 377-385, 2001."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"BETTELI E, KORN T, OUKKA M, KUCHROO VK: Induction and effector functions of TH17 cells. Nature 453: 1051-1057, 2008.","DOI":"10.1038\/nature07036"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"BEVAART L, VERVOORDELDONK MJ, TAK PP: Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis? Arthritis Rheum 62: 2192-2205, 2010.","DOI":"10.1002\/art.27503"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"BUSH KA, WALKER JS, LEE CS, KIRKHAM BW: Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early disease. Clin Exp Immunol 123: 487-495, 2001.","DOI":"10.1046\/j.1365-2249.2001.01469.x"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"CHEN L, DENG H, CUI H, FANG J, ZUO Z, DENG J, LI Y, WANG X, ZHAO L: Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9: 7204-7218, 2017.","DOI":"10.18632\/oncotarget.23208"},{"key":"ref13","unstructured":"DESAI S, DESAI DG, KAUR H: Saponins and their biological activities. Pharma Times 41: 13-16, 2009."},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"DRAFI F, BAUEROVA K, KUNCIROVA V, PONIST S, MIHALOVA D, FEDOROVA T, HARMATHA J, NOSAL R: Pharmacological influence on processes of adjuvant arthritis: effect of the combination of an antioxidant active substance with methotrexate. Interdiscip Toxicol 5: 84-91, 2012.","DOI":"10.2478\/v10102-012-0015-4"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"EBRAHIMI H, FALLAHI M, KHAMANEH AM, EBRAHIMI SAADATLOU MA, SAADAT S, KEYHANMANESH R: Effect of \u03b1-hederin on IL-2 and IL-17 mRNA and miRNA-133a levels in lungs of ovalbumin-sensitized male rats. Drug Dev Res 77: 87-93, 2016.","DOI":"10.1002\/ddr.21292"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"FEKETEOVA L, JAN\u010cOVA P, MORAVCOVA P, JANEGOVA A, BAUEROVA K, PONI\u0160T S, MIHALOVA D, JANEGA P, BABAL P: Effect of methotrexate on inflammatory cells redistribution in experimental adjuvant arthritis. Rheumatol Int 32: 3517-3523, 2012.","DOI":"10.1007\/s00296-011-2177-3"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"FITZPATRICK LR, STONESIFER E, SMALL JS, LIBY KT: The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in mice. Inflammopharmacology 22: 341-349, 2014.","DOI":"10.1007\/s10787-014-0203-2"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"FOURNIER C: Where do T cells stand in rheumatoid arthritis? Joint Bone Spine 72: 527-532, 2005.","DOI":"10.1016\/j.jbspin.2004.12.012"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"GANESAN R, RASOOL M: Interleukin 17 regulates SHP-2 and IL-17RA\/STAT-3 dependent Cyr61, IL-23 and GM-CSF expression and RANKL mediated osteoclastogenesis by fibroblast-like synoviocytes in rheumatoid arthritis. Mol Immunol 9: 134-144, 2017.","DOI":"10.1016\/j.molimm.2017.09.003"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"GETIA M, MSHVILDADZE V, PICHETTE A, DEKANOSIDZE G, KEMOKLIDZE Z: Development of analytical procedure for the quantification of \u201cFatsiflogin\u201d. J Pharmacy 7: 96-99, 2017.","DOI":"10.9790\/3013-0703019699"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"HAZLEWOOD GS, BARNABE C, TOMLINSON G, MARSHALL D, DEVOE D, BOMBARDIER C: Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis. BMJ 353: i1777, 2016.","DOI":"10.1136\/bmj.i1777"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"HOU W, MENG L, WEN Y, ZHU W, JIANG C, HE X, ZHOU Y, LU S: Methotrexate ameliorates pristane-induced arthritis by decreasing IFN-\u03b3 and IL-17A expressions. J Zhejiang Univ Sci B 12: 40-46, 2011.","DOI":"10.1631\/jzus.b1000078"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"IVANOV II, MCKENZIE BS, ZHOU L, TADOKORO CE, LEPELLEY A, LAFAILLE JJ, CUA DJ, LITTMAN DR: The orphan nuclear receptor ROR\u03b3t directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133, 2006.","DOI":"10.1016\/j.cell.2006.07.035"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"KANG GD, LIM S, KIM DH: Oleanolic acid ameliorates dextran sodium sulfate-induced colitis in mice by restoring the balance of Th17\/Treg cells and inhibiting NF-\u03baB signaling pathway. Int Immunopharmacol 29: 393-400, 2015.","DOI":"10.1016\/j.intimp.2015.10.024"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"KEMERTELIDZE E, KEMOKLIDZE Z, DEKANOSIDZE G, BEREZNYAKOVA A: Triterpene glycosides of Fatsia japonica cultivated in Georgia and their pharmacological activity. Pharmaceutic Chem J 35: 229-432, 2001.","DOI":"10.1023\/a:1013732206094"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"KOZIOLOV\u00c1 E, VENCL\u00cdKOV\u00c1 K, ETRYCH T: Polymer-drug conjugates in inflammation treatment. Physiol Res 67 (Suppl 2): S281-S292, 2018.","DOI":"10.33549\/physiolres.933977"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"MAROON JC, BOST JW, MAROON A: Natural anti-inflammatory agents for pain relief. Surg Neurol Int 1: 80, 2010.","DOI":"10.4103\/2152-7806.73804"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"MESGARZADEH I, AKBARZADEH AR, RAHIMI R: Surface active properties of solvent extracted Panax ginseng saponin based surfactants. J Surfact Deterg 20: 609-614, 2017.","DOI":"10.1007\/s11743-017-1940-1"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"MIRANDA-CARUS ME, BALSA A, BENITO-MIGUEL M, PEREZ DE AYALA C, MARTIN-MOLA E: IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate. J Immunol 173: 1463-1476, 2004.","DOI":"10.4049\/jimmunol.173.2.1463"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"MOSMANN TR, COFFMAN RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173, 1989.","DOI":"10.1146\/annurev.iy.07.040189.001045"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"MUCIDA D, PARK Y, KIM G, TUROVSKAYA O, SCOTT I, KRONENBERG M, CHEROUTRE H: Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260, 2007.","DOI":"10.1126\/science.1145697"},{"key":"ref32","unstructured":"ONDREJICKOVA O, ZIEGELHOEFFER A, GABAUER I, SOTNIKOVA R, STYK J, GIBALA P, SEDLAK J, HORAKOVA L: Evaluation of ischemia-reperfusion injury by malondialdehyde, glutathione and gamma-glutamyl transpeptidase: lack of specific local effects in diverse parts of the dog heart following acute coronary occlusion. Cardioscience 4: 225-230, 1993."},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"ORLOWSKI M, MEISTER A: The gamma-glutamyl cycle: a possible transport system for amino acids. Proc Natl Acad Sci U S A 67: 1248-1255, 1970.","DOI":"10.1073\/pnas.67.3.1248"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"PHILLIPS DC, WOOLLARD KJ, GRIFFITHS HR: The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species. Br J Pharmacol 138: 501-511, 2003.","DOI":"10.1038\/sj.bjp.0705054"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"PONI\u0160T S, SLOV\u00c1K L, KUNC\u00cdROV\u00c1 V, FEDOROVA T, LOGVINENKO A, MUZYCHUK O, MIHALOV\u00c1 D, BAUEROV\u00c1 K: Inhibition of oxidative stress in brain during rat adjuvant arthritis by carnosine, trolox and novel trolox-carnosine. Physiol Res 64 (Suppl 4): S489-S496, 2015.","DOI":"10.1515\/afpuc-2016-0001"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"SGLUNDA O, MANN HF, HULEJOV\u00c1 H, PECHA O, PLE\u0160TILOV\u00c1 L, R\u016e\u017dI\u010cKOV\u00c1 O, FOJT\u00cdKOV\u00c1 M, SL\u00c9GLOV\u00c1 O, FOREJTOV\u00c1 S, PAVELKA K, VENCOVSK\u00dd J, SENOLT L: Decrease in serum interleukin-21 levels is associated with disease activity improvement in patients with recent-onset rheumatoid arthritis. Physiol Res 63: 475-481, 2014.","DOI":"10.1136\/annrheumdis-2014-eular.4092"},{"key":"ref37","unstructured":"SHALAMBERIDZE L, TSITLANADZE V, KEMERTELIDZE E, KARTVELSHVILI E: Fatsiphlogin\u00ae - new plant origin preparation in therapy of RA (Rheumatoid Arthritis). Ross Revmatol 1: 43-45, 1998."},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"SMOLEN SJ, LANDEW\u00c9 R, BREEDVELD CF, DOUGADOS M, EMERY P, GAUJOUX-VIALA C, GORTER S, KNEVEL R, NAM J, SCHOELS M, ALETAHA D, BUCH M, GOSSEC L, HUIZINGA T, BIJLSMA JW, BURMESTER G, COMBE B, CUTOLO M, GABAY C, GOMEZ-REINO J, KOULOUMAS M, KVIEN TK, MARTIN-MOLA E, MCINNES I, PAVELKA K, VAN RIEL P, SCHOLTE M, SCOTT DL, SOKKA T, VALESINI G, VAN VOLLENHOVEN R, WINTHROP KL, WONG J, ZINK A, VAN DER HEIJDE D: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 69: 964-975, 2010.","DOI":"10.1136\/ard.2009.126532"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"SPARG SG, LIGHT ME, STADEN J: Biological activities and distribution of plant saponins. Ethnopharmacology 94: 219-243, 2004.","DOI":"10.1016\/j.jep.2004.05.016"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"STOLINA M, BOLON B, MIDDLETON S, DWYER D, BROWN H, DURYEA D, ZHU L, ROHNER A, PRETORIUS J, KOSTENUIK P, FEIGE U, ZACK D: The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis. J Clin Immunol 29: 158-174, 2009.","DOI":"10.1007\/s10875-008-9238-8"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"SULTANA N, SAIFY ZS: Naturally occurring and synthetic agents as potential anti-inflammatory and immunomodulants. Antiinflamm Antiallergy Agents Med Chem 11: 3-19, 2012.","DOI":"10.2174\/187152312803476264"},{"key":"ref42","unstructured":"TSIKLAURI L, DELATTRE L, DEKANOSIDZE G, SULAKVELIDZE TS, KEMOKLIDZE Z, KEMERTELIDZE E: Fatsiflogin tablets: composition design and technology development. Farmacia 4: 36-39, 2004."},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"VAN EDEN W, WAGENAAR-HILBERS JP, WAUBEN MH: Adjuvant arthritis in the rat. Curr Protoc Immunol 19: 15.4.1-15.4.8, 1996.","DOI":"10.1002\/0471142735.im1504s19"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"WALTHELM U, DITTRICH K, GELBRICH G, SCH\u00d6PKE T: Effects of saponins on the water solubility of different model compounds. Plantamedica 67: 49-54, 2001.","DOI":"10.1055\/s-2001-10876"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"WANG H, GAO J, KOU J, ZHU D, YU B: Anti-inflammatory activities of triterpenoid saponins from Polygala japonica. Phytomedicine 15: 321-326, 2008.","DOI":"10.1016\/j.phymed.2007.09.014"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"WU YQ, WANG YL, LEI TZ, XIA YQ: The solubilization capability of polycyclic aromatic hydrocarbons enhanced by biosurfactant saponin mixed with conventional chemical surfactants. Pet Sci Technol 32: 108-115, 2014.","DOI":"10.1080\/10916466.2011.653467"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T14:41:30Z","timestamp":1574952090000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomed.cas.cz\/physiolres\/pdf\/68\/68_S75.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":47,"URL":"https:\/\/doi.org\/10.33549\/physiolres.934328","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,31]]}}}